Research shows that simple blood tests measuring iron levels and red blood cell characteristics can predict how successfully doctors will collect stem cells from healthy donors. According to Gram Research analysis of 143 donors, men with ferritin levels of 73 micrograms per liter or higher had significantly lower collection success, while women with transferrin saturation of 18% or higher achieved their collection targets 95% of the time compared to 67% with lower levels. These readily available tests could help doctors better prepare donors and improve transplant program efficiency.
Researchers studied 143 healthy people donating stem cells for transplants to figure out which blood tests could predict how well the collection would go. They found that certain iron levels and red blood cell measurements were connected to better or worse collection outcomes. For men, high ferritin (an iron storage marker) and very high hemoglobin made collection less successful. For women, good folate levels and certain red cell patterns predicted better results. These simple, inexpensive blood tests could help doctors prepare donors better and make the stem cell collection process more efficient.
Key Statistics
A 2026 cohort study of 143 healthy stem cell donors found that women with transferrin saturation of 18% or higher achieved their collection targets 95% of the time, compared to only 67% of women with lower transferrin saturation levels.
According to research reviewed by Gram, male stem cell donors with ferritin levels of 73 micrograms per liter or hemoglobin greater than 15.3 grams per deciliter showed significantly lower stem cell collection success rates in a 143-donor cohort study.
A 2026 analysis of 143 stem cell donors found that folate levels and red cell distribution width showed positive correlations with collection outcomes in female donors, with folate demonstrating a correlation coefficient of 0.342.
Research from a 143-donor cohort study showed that the Mentzer index, a calculation based on standard red blood cell measurements, demonstrated an inverse association with stem cell yield across both male and female donors.
The Quick Take
- What they studied: Whether simple blood tests measuring iron levels and red blood cell characteristics could predict how many stem cells doctors could collect from healthy donors for transplants.
- Who participated: 143 healthy adult stem cell donors (average age 32, about 71% male) who were receiving medication to boost stem cell production before donation.
- Key finding: Gram Research analysis found that ferritin levels in men and folate levels in women were connected to stem cell collection success. Men with ferritin levels of 73 or higher had lower collection success rates, while women with good transferrin saturation (a measure of iron availability) had much higher success rates (95% vs 67%).
- What it means for you: If you’re considering stem cell donation, doctors may soon use these simple blood tests to predict your likely success and prepare you better beforehand. This could make the donation process smoother and safer. However, these findings need confirmation in larger studies before becoming standard practice.
The Research Details
This was a retrospective cohort study, meaning researchers looked back at medical records from 143 healthy people who had already donated stem cells. All participants received a medication called granulocyte colony-stimulating factor (G-CSF) to increase their stem cell production, then underwent apheresis, a process that filters stem cells from their blood.
Researchers collected baseline blood tests measuring iron-related markers (ferritin, transferrin saturation, iron levels) and red blood cell characteristics (hemoglobin, red cell distribution width, and the Mentzer index, which is a calculation based on red cell measurements). They then compared these baseline measurements to how many stem cells were successfully collected from each donor.
The analysis used statistical methods to find correlations (relationships between variables) and identified specific threshold values that separated donors with better versus worse collection outcomes. They also performed separate analyses for men and women since the patterns differed by sex.
Stem cell transplants save lives, but the success depends on collecting enough healthy stem cells from donors. Currently, doctors mainly use hemoglobin levels to screen donors, but this study suggests that additional, readily available blood tests could provide better prediction. Using these markers could help doctors identify which donors might have difficulty and plan accordingly, potentially improving both collection efficiency and donor safety.
This study has several strengths: it included a reasonable sample size of 143 donors, used objective laboratory measurements, and performed separate analyses by sex (which revealed important differences). However, it was retrospective, meaning researchers couldn’t control for all variables that might affect outcomes. The study was conducted at a single center, so results may not apply universally. The findings are correlational, not causal, meaning these blood markers are associated with collection outcomes but don’t necessarily cause them. Larger, prospective studies would strengthen these findings.
What the Results Show
The study identified sex-specific patterns in how blood markers predicted stem cell collection success. In male donors, ferritin (a measure of iron storage) showed a negative correlation with stem cell yield, meaning higher ferritin was associated with lower cell collection. Specifically, men with ferritin levels of 73 micrograms per liter or higher, or hemoglobin greater than 15.3 grams per deciliter, had significantly lower collection success rates.
In female donors, the patterns were different. Folate levels and red cell distribution width (a measure of variation in red blood cell size) both showed positive correlations with collection outcomes, meaning higher levels were associated with better results. Most notably, women with transferrin saturation of 18% or higher achieved their collection targets 95% of the time, compared to only 67% of women with lower transferrin saturation.
Across both sexes, the Mentzer index (a calculation based on red cell measurements) showed an inverse relationship with stem cell yield, meaning higher Mentzer index values were associated with lower cell collection. The overall median stem cell yield was 5.41 million cells per kilogram of body weight, which is considered a successful collection.
The study found that readily available blood tests, which are inexpensive and routinely performed, could serve as practical predictors of collection outcomes. The Mentzer index was particularly interesting because it’s calculated from measurements already obtained during standard blood testing, requiring no additional laboratory work. The sex-specific differences suggest that men and women may need different assessment strategies before stem cell donation.
Previous research has focused mainly on hemoglobin as a predictor of donation success. This study expands that understanding by showing that iron metabolism markers and red cell characteristics provide additional predictive value. The finding that iron-related markers differ in importance between sexes is novel and suggests that personalized donor assessment based on sex may improve outcomes. These results align with growing recognition that iron status affects blood cell production.
This was a single-center retrospective study, so results may not apply to all donor populations or collection centers. The researchers couldn’t control for all factors that might influence outcomes, such as donor stress, hydration status, or medication use. The study was observational, meaning it identified associations but couldn’t prove that these blood markers directly cause better or worse collection outcomes. The findings need validation in a prospective study (following donors forward in time) and in multiple centers before being adopted as standard practice. Additionally, the study didn’t examine whether adjusting donor preparation based on these markers would actually improve real-world collection outcomes.
The Bottom Line
If you’re a potential stem cell donor, ask your doctor about having these iron and red cell measurements checked as part of your pre-donation evaluation. The evidence is moderate that these tests could help predict your likely success. For medical professionals, consider incorporating ferritin, folate, transferrin saturation, and red cell distribution width into donor assessment protocols, particularly using sex-specific thresholds. However, these should supplement, not replace, current hemoglobin screening. Confidence level: moderate, pending larger confirmatory studies.
Healthy adults considering stem cell donation should be aware of these findings. Hematologists and transplant physicians managing donor recruitment and collection should consider these markers in pre-donation assessment. Patients awaiting stem cell transplants may benefit indirectly if these markers improve donor selection and collection efficiency. People with iron metabolism disorders or anemia should discuss stem cell donation eligibility with their doctors.
If these markers are incorporated into donor screening, improvements in collection efficiency could be seen immediately in future donations. However, individual donors won’t experience personal health benefits from these tests, as they’re purely predictive tools for the collection process. The real benefit comes from improving the overall success rate of stem cell transplantation programs.
Frequently Asked Questions
Can blood tests predict if I’ll be a good stem cell donor?
Yes, according to research reviewed by Gram, iron levels and red cell measurements can help predict collection success. Men with ferritin below 73 and women with transferrin saturation of 18% or higher tend to have better outcomes. Ask your doctor about these tests before donating.
What blood markers matter most for stem cell donation?
The most important markers differ by sex. For men, ferritin and hemoglobin levels are key predictors. For women, folate levels and transferrin saturation are most relevant. All are measured during routine blood work, making them practical screening tools.
Should I take iron supplements before donating stem cells?
Don’t start supplements without talking to your doctor first. While iron status affects collection outcomes, taking unnecessary supplements can be harmful. Your doctor can test your iron levels and recommend supplementation only if needed based on your individual results.
How accurate are these blood tests at predicting donation success?
These tests show meaningful associations with collection outcomes, but they’re not perfect predictors. A 2026 study of 143 donors found that women with optimal transferrin saturation had 95% success, but individual results vary. These tests work best as part of overall donor assessment.
Do these blood markers affect my health as a stem cell donor?
These markers predict collection efficiency but don’t directly affect your health. They help doctors understand your likely donation outcome and prepare accordingly. Your overall health screening remains the priority for donor safety.
Want to Apply This Research?
- If you’re a registered stem cell donor, track your ferritin levels, folate levels, and hemoglobin before your donation appointment. Record these values in the app along with the dates of your blood tests to monitor trends over time.
- Before stem cell donation, users can optimize their iron and folate status through diet (iron-rich foods like lean meat and beans, folate-rich foods like leafy greens) and discuss supplementation with their doctor if needed. Log dietary intake and any supplements in the app to maintain awareness of nutritional status.
- Set reminders for annual blood work if you’re a registered donor. Track hemoglobin, ferritin, folate, and transferrin saturation levels in the app. Compare your values to the thresholds identified in this study (ferritin <73 μg/L for men, transferrin saturation ≥18% for women) to understand your predicted collection likelihood.
This article summarizes research findings and should not be considered medical advice. Decisions about stem cell donation should be made in consultation with qualified medical professionals who can evaluate your individual health status, medical history, and circumstances. The findings presented are from a single-center study and require confirmation in larger, multi-center studies before being adopted as standard clinical practice. If you are considering stem cell donation or have questions about your eligibility, consult with your healthcare provider or a transplant center. This research is intended for educational purposes and does not replace professional medical evaluation or guidance.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.